1. Introduction {#sec1}
===============

A common characteristic of retinal degeneration is reactive gliosis, a term coined to describe a process where Müller glia rapidly proliferate ([@bib11]), undergo morphological changes ([@bib32]), and release pro-inflammatory and regulatory factors into the local retinal environment ([@bib6]). This process, thought to protect the retina from further damage, is not always beneficial and can lead to the formation of glial scarring which further aggravates retinal degeneration ([@bib7]). As Müller cell gliosis is the main characteristic of retinal degenerative disorders ([@bib13]; [@bib15]; [@bib42]; [@bib56]), a greater understanding of the molecular events that occur in this process is required to develop therapeutic strategies to promote self-repair and consequently endogenous regeneration.

Müller glia provide structural and homeostatic support to retinal neurons and constitute the first line of reactivity upon retinal damage. Whilst Müller glia are responsible for the regeneration observed in zebrafish retina after injury, there is no evidence that these cells have regenerative ability in humans. On the contrary, Müller cells are known to undergo changes which lead to reactive gliosis and scarring of the human retina ([@bib7]). A population of Müller glia with stem cell characteristics (hMSC) has been identified in the adult human retina ([@bib4]; [@bib29]). Upon isolation *in vitro* these cells become spontaneously immortalized ([@bib33]) and can be induced to express markers of retinal ganglion cells or photoreceptor neurons by culture with growth and differentiation factors ([@bib22]; [@bib44]). In addition, Müller glia can be induced to proliferate *in situ* in human retinal explants cultured with growth and differentiation factors ([@bib3]). Although there is no evidence that Müller glia proliferate or neurally differentiate *in situ*, the observations that they can proliferate indefinitely *in vitro* and differentiate into retinal neurons upon culture with differentiation factors, suggest that Müller glia may have the potential to repair the human retina *in vivo.* However for unknown developmental reasons, they are prevented from exerting this regenerative function.

Various studies have examined the proteome profile of the retina using experimental disease models ([@bib5]; [@bib27]; [@bib35]; [@bib48]), but proteomic investigations of the gliotic human retina have been limited. Recent studies however, have identified 3436 non-redundant proteins in the normal human retina ([@bib58]), contributing to the mapping of the human retinal proteome which may aid investigations into disease mechanisms. Several proteomic studies on the characterisation of Müller glia has been performed on cells isolated from rodent or porcine retina ([@bib16]; [@bib18]; [@bib36]), but investigations into the proteomic profile of human Müller glia in the context of retinal gliosis have not been reported. This study has therefore attempted to examine the contribution of human Müller glia to the proteomic profile of the gliotic human retina by comparing the protein expression profiles of gliotic and normal human retina with that of Müller glia cell lines *in vitro*.

2. Materials and methods {#sec2}
========================

2.1. Tissue acquisition {#sec2.1}
-----------------------

Retinae from four normal cadaveric donors with prior consent for research were obtained from Moorfields eye Bank under 24 h post mortem. Specimens for protein analysis were obtained by excising sections of normal peripheral retina between 1 and 3 mm x 1--5 mm (3--5 mm^2^) to match the size of the retinectomy specimens obtained. Six peripheral retinectomy specimens (3--5 mm^2^) from eyes undergoing retinal surgery for treatment of proliferative vitreo-retinopathy (PVR) (duration of 2--10 weeks) were obtained according to guidelines from the Local Ethics Committee at Moorfields and the Institute of Ophthalmology and followed the tenets of the Declaration of Helsinki. Donors ages ranged from 32 to 83yrs and matched where possible. Before pooling for the proteomics assays, specimens were washed in phosphate buffered saline (PBS) and frozen at −80 °C until use.

2.2. Cell culture {#sec2.2}
-----------------

The immortalized human Müller cell line MIO-M1 ([@bib33]) was used in this study along with the immortalized Müller cell preparations 6387 (MIO-M7), 6391(MIO-M4) and 6390 (MIO-M5) generated in our laboratory. Cells were grown to confluence in 10% foetal calf serum (FCS, Invitrogen, UK) in DMEM with GlutaMAX (31966-021; Invitrogen UK) at 37 °C in the presence of 5% CO~2~.

2.3. Protein isolation and proteomic analysis of human retina and Müller glial cells {#sec2.3}
------------------------------------------------------------------------------------

Retinal fragments and Müller cell preparations were washed in PBS prior to homogenisation with 50 nM Ammonium Bicarbonate +2%ASB-14 (Sigma Aldrich, UK) pH8.2. Protein content was estimated using the Bicinchoninic Acid (BCA) protein assay kit (Sigma-Aldrich, UK).

2.4. 2-Dimensional gel electrophoresis (2D-DIGE) assay {#sec2.4}
------------------------------------------------------

Human retina protein isolated from 4 normal, 5 gliotic specimens, as well as 4 Müller glia cell preparations were combined to create 3 separate pools, each consisting of 150 μg of protein. 2D-DIGE analyses were performed as previously described ([@bib19]). Each protein pool was labelled with a different CyDye (600 pmol) as follows: Control retina was labelled with Cy3; gliotic retina with Cy5 and Müller glia with Cy2. Samples were then combined and added to Immobiline DryStrip gels (IPG) and run on an IPG Multiphor II Electrophoresis System (GE Healthcare, Little Chalfont, U.K.). For the second dimension, Isoelectric focusing (IEF) strips were re-equilibrated before resolving samples on an Ettan DALT twelve System separation tank using 12% acrylamide gels. Gels were fixed and imaged using a Typhoon scanner (Model 8600, GE Healthcare, UK). Spot comparison was performed using Progenesis Samespots software (Non-Linear Dynamics, Waters, UK). Gels were silver stained ([@bib19]) and protein spots excised, trypsin digested and processed as for mass spectrometry.

2.5. Label free proteomics {#sec2.5}
--------------------------

Similarly, three different pools from normal, gliotic human retina and Müller glia were used for label free proteomics. Freeze-dried samples (80 μg each) were reconstituted in homogenisation buffer (50 mM AmmoniumBicarb + 2%ASB-14) and run on a 1D gel (BioRad Mini Protean Precast gels, BioRad, UK) as described previously ([@bib19]). Ten gel bands of each sample lane were excised according to molecular weight and subjected to trypsin digestion and peptide extraction as previously described ([@bib2]). Digests were reconstituted in 30 μl of 3%ACN +0.1% Trifluoroacetic acid (TFA) with yeast enolase added as an internal standard and analysed using a QToF Premier™ mass spectrometer coupled to a NanoAquity Nano-LC system (Waters Corp, UK).

2.6. Data analysis {#sec2.6}
------------------

Specimens (normal retina, gliotic retina and Müller glia) were assessed for differentially expressed proteins giving an n number of 1 for each condition. Therefore, the high cut-off values of ≥2-fold upregulated or ≤0.5-fold downregulated were chosen to obtain higher confidence when analysing the data.

Proteins were identified using ProteinLynx Global Server (PLGS) 2.4 (Waters, UK) with a downloaded Uniprot reference proteome for homo sapiens with porcine trypsin (Accession: P00761) and yeast enolase (Accession: P00924) added. Results generated were further processed through Progenesis QI software (Non-linear dynamics, Waters UK). Only proteins identified by 2 or more peptides were used in comparative analyses, [Supplementary Table 1](#appsec1){ref-type="sec"} contains the list of proteins used in the analysis. Further analyses of the results were conducted on web-based platforms including the Panther Classification System (<http://www.pantherdb.org/>), ([@bib37]) gene ontology classification by WebGestalt (<http://bioinfo.vanderbilt.edu/webgestalt/>) ([@bib54]) and IMPaLA (<http://impala.molgen.mpg.de/>) for pathway analysis ([@bib25]).

Mass spectrometry proteomics data have been deposited in the ProteomeXchange Consortium database (<http://proteomecentral.proteomexchange.org>) via the PRIDE partner repository ([@bib52]) with the dataset identifier PXD008485.

2.7. Western blot analysis {#sec2.7}
--------------------------

Cell lysis and western blot analysis was performed as previously described ([@bib29]). Aliquots of cell lysates were resolved on 4--12% NuPAGE Bis-Tris gels (Invitrogen, U.K.). Proteins were transferred to PDVF membranes (Semi-dry transfer, Biorad,UK) and blocked with 5% FBS and 5% skimmed milk powder in TBS. Immunodetection was performed using primary antibodies against vimentin (1:250; Santa Cruz), galectin-1 (1:5000; Abcam), and GFAP (1:2000; DAKO). Protein bands were detected following incubation with donkey antiserum against rabbit, or mouse IgG coupled to horseradish peroxidase (Santa Cruz Biotechnology Inc). Chemiluminescence was detected using Millipore Luminata detection reagents and resolved using an x-ray developer.

2.8. Immunohistochemistry {#sec2.8}
-------------------------

Human tissue samples from normal retina or gliotic PVR retina were fixed in 4% PFA for 30mins, cryopreserved in 30% sucrose and embedded in OCT for cryosectioning. For immunostaining, sections were blocked (TBS + 0.3% triton X 5% donkey serum) for 1 h prior to the addition of the primary antibody, incubated overnight at 4 ° C. Sections were then washed with TBS and incubated in secondary antibodies (Alexa flour, 1:500 in TBS + 0.3% triton) for 3 hrss at room temperature in the dark. Slides were then washed in TBS and counterstained with a mounting medium containing DAPI (Fluoroshield; Abcam) before coverslipping.

3. Results {#sec3}
==========

3.1. Proteomic profiles of Müller glial cell lines and of normal and gliotic human retina examined by label free analysis {#sec3.1}
-------------------------------------------------------------------------------------------------------------------------

Analysis of protein expression by label free mass spectrometry identified 1527 proteins in Müller glial cell preparations, 1631 proteins in normal retina and 1074 in gliotic PVR retina. In Müller glial cell preparations vimentin exhibited the highest abundancy (14% of total protein), but GFAP only constituted 1.43% of the protein content. Other proteins highly expressed in Müller glia included histone H4 (6.17%), actin cytoplasmic 1 (3.56%) and annexin A2 (3.02%) ([Fig. 1](#fig1){ref-type="fig"}A). In normal retina GAPDH was the most abundant protein and constituted 6.06% of the total protein. This was followed by vimentin (5.04%), alpha enolase (5.02%) and creatine kinase b type (4%) ([Fig. 1](#fig1){ref-type="fig"}B). In gliotic retina, vimentin was the most abundant protein, constituting 13.4% of total protein, followed by GFAP (7.4%), histone H4 (5.58%) and alpha enolase (5.54%) ([Fig. 1](#fig1){ref-type="fig"}C). [Supplementary Table 1](#appsec1){ref-type="sec"} shows the full list of identified proteins in each group which were used for analysis.Fig. 1**Abundance of proteins as identified by label free mass spectrometry analysis in normal retina, gliotic retina and Müller glia**. For clarity only proteins with the highest abundance are labelled. (A) Pie chart shows protein abundance represented as percentage of total protein identified in a pool of Müller glial cell lysate. (B) Pie chart shows protein abundance represented as percentage of total protein identified in a pool of 4 normal retinae. (C) Pie chart shows protein abundance represented as percentage of total protein identified in a pool of 5 gliotic retinae.Fig. 1

3.2. Differences in protein expression between normal and gliotic PVR retina and Müller glial profile {#sec3.2}
-----------------------------------------------------------------------------------------------------

As identified by label free mass spectrometry and based on a \>2-fold increase in expression, 28 proteins were upregulated in the gliotic retina as compared to normal retina. Quinone oxidoreductase exhibited the highest fold change (9.22-fold) followed by CD166 (8.2-fold) and protein canopy homolog 2 (6.83-fold). A large proportion of upregulated proteins are involved in cytoskeletal regulation and included the filament proteins ezrin, glial fibrillary acidic protein, desmin and vimentin. Nucleic acid binding proteins were also upregulated in gliotic retina and included histones, ribosomal proteins and poly-ubiquitin ([Table 1](#tbl1){ref-type="table"}). Interestingly, all the proteins found upregulated in the gliotic retina, were also present in the Müller cell preparation. These have been highlighted in [Table 1](#tbl1){ref-type="table"}, showing the associated ranked abundancies within the Müller cell preparation. Of the 30 most abundant proteins identified by mass spectrometry in Müller glial cell lysates, vimentin showed the highest abundance, followed by histone H4 and actin cytoplasmic 1 ([Fig. 2](#fig2){ref-type="fig"}). Four of the 30 most abundant proteins observed in Müller cell preparations were found highly upregulated in the gliotic retina as compared to normal retina. These included vimentin, GFAP, heat shock protein 90α and polyubiquitin C ([Fig. 2](#fig2){ref-type="fig"}).Table 1**Proteins upregulated** \> **2-fold in gliotic human retina compared to normal retina.** Table shows the proteins found upregulated \>2-fold in the gliotic retina as compared to normal retina. They have been grouped according to their major functions for clarity. Ranked abundancies for each protein found in the Müller cell preparation are listed (Low numbers indicate higher abundancy, e.g. 1 = highest abundant protein in the Müller cell preparation).Table 1Protein ClassUpregulatedRanked Abundance in Müller preparationProteinAccessionNo. PeptidesFold changeCell adhesion moleculeCD166 antigenQ1374038.20274Galectin 1P09382252.0356ChaperoneHeat shock protein HSP90 alphaP07900762.023Heat shock 70 kDa protein 1P34931326.7039614 3 3 protein sigmaP31947214.31216Structural molecule activityEzrinP15311205.25280Glial fibrillary acidic proteinP141362174.5015DesminP17661564.84154Synapsin 1P1760025.39369Keratin type 1 cytoskeletal 16P08779183.37358Tubulin alpha 1A chainQ71U361992.6486VimentinP086704322.531Profilin 1P07737212.0136Membrane trafficking proteinSynapsin 1P1760025.39369Nucleic acid bindingHistone H2B type 1P235271433.80289Small nuclear ribonucleoprotein SM D3P6231842.83178Polyubiquitin 3P0CG48372.062840s ribosomal protein s20P6086622.3227260s ribosomal protein L36Q9Y3U853.9053Histone H1 3P16402232.0181Signalling moleculeGalectin 1P09382252.0256Tenascin CP2482122.54188OxioreductaseProcollagen lysine 2 oxoglutarate 5 dioxygenase 2O0046962.31158D3 phosphoglycerate dehydrogenaseO4317532.13375Quinone oxidoreductaseQ0825749.2275MISCTranslocon associated protein subunit deltaP5157142.17256Protein canopy homolog 2Q9Y2B026.83354Fig. 2**Proteins upregulated in the gliotic retina are among the 30 most abundant proteins expressed by Muller glia**. Venn diagram shows the proteins upregulated in the gliotic human retina (yellow area) and the 30 most abundant proteins in the Müller glia cell preparation (blue area) and the common proteins to both groups (green area). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 2

Well known Müller glia markers were also predominant in Müller cell preparations and included glutamine synthetase, retinaldehyde binding protein 1 and CD44-antigen. Of these, both glutamine synthetase and retinaldehyde binding protein 1 were downregulated in the gliotic retina as compared to normal retina. Several proteins present in Müller cell lysates have not been previously identified in Müller glia and included prelamin A/C, elongation factor 1, and serpin H1. Further details can be found in [Supplementary Table 2](#appsec1){ref-type="sec"}.

Based on \<0.5-fold decrease in expression, 196 proteins were downregulated in the gliotic retina as compared to normal retina. Mitochondrial 2 oxoglutarate malate carrier protein showed the greatest decrease in the gliotic retina (0.005-fold), followed by Tubulin alpha 8 chain (0.01-fold) and reticulon 4 (0.1-fold). The majority of downregulated proteins identified are involved in nucleic acid binding including ribosomal related proteins ([Table 2](#tbl2){ref-type="table"}).Table 2**Proteins downregulated in the gliotic human retina compared to normal retina.** Table shows the 50 proteins found to be downregulated \<0.5-fold in the gliotic retina as compared to normal retina. They have been grouped according to their major functions for clarity.Table 2Protein ClassDownregulatedProteinAccessionNo.PeptidesFold changeChaperonePutative Heat shock protein 90 beta 2Q58FF8350.04  Structural molecule activityKeratin type II cuticular Hb3P78385110.06Tubulin alpha 8 chainQ9NY65830.01Keratin type II cuticular Hb2Q9NSB430.08Neurofilament medium polypeptideP07197160.06Tropomyosin alpha 1 chainP09493180.07Membrane trafficking proteinReticulon 4Q9NQC320.01Endoplasmic reticulum resident protein 29P3004050.15Coatomer subunit alphaP5362140.12Nucleic acid bindingMatrin 3P4324330.09Proliferating cell nuclear antigenP1200420.0460S ribosomal protein L24P8373130.04Poly rC binding protein 3P5772170.03Poly ADP ribose polymerase 1P0987420.0240S ribosomal protein S11P6228070.11Transcriptional activator protein Pur alphaQ0057720.08ADP ATP translocase 1P12235460.0740S ribosomal protein S4 XP6270160.0260S ribosomal protein L13aP4042920.1340S ribosomal protein S9P4678180.09Core histone macro H2A 1O75367130.1360S ribosomal protein L13P2637340.02Mitochondrial 2 oxoglutarate malate carrier proteinQ0297860.00540S ribosomal protein S26P6285430.1260s Ribosomal protein L14P5091460.11Non histone chromosoaml protein HMGP0511450.1440S ribosomal protein S23P6226620.13Polyadenylate binding protein 1Q4VXU220.13ATP synthase subunit gamma mitochondrialP3654290.14Guanine nucleotide binding protein GIGSGT subunit beta 1P62873291.13Adenylate kinase isoenzyme 1P0056820.14Signalling moleculeMembrane associated progesterone receptor component 1O0026440.12TransferaseHypoxanthine guanine phosphoribosyltransferaseP0049240.03Creatine kinase U type mitochondrialP1253240.07ATP citrate synthaseP5339640.12Guanylate kinaseQ1677440.09OxioreductasePeroxiredoxin 4Q13162100.06NADH cytochrome b5 reductase 3P0038760.08Estradiol 17 beta dehydrogenase 12Q53GQ020.05Glycerol 3 phosphate dehydrogenase mitochondrialP4330430.07Isocitrate dehydrogenase NAD subunit alphaP5021340.14Procollagen lysine 2 oxoglutarate 5 dioxygenase 3O6056870.15DetoxificationGlutathione S-transferase Mu 2P2816140.02Enzymes/modulatorsInterleukin enhancer binding factor 3Q12960650.14Inorganic pyrophosphataseQ1518130.02Poly rC binding protein 2Q1536680.14Transcription factorCullin associated NEDD8 dissociated protein 1Q86VP630.10Transcriptional activator protein Pur alphaQ0057720.08MISCProteasome subunit alpha type 7O1481820.06ProhibitinP3523280.13Thioredoxin domain containing protein 5Q8NBS920.13

3.3. Comparative analysis of protein expression between Müller glia and normal and gliotic PVR retina as examined by 2D-DIGE {#sec3.3}
----------------------------------------------------------------------------------------------------------------------------

Approximately 200 protein spots were detected in the 2D-DIGE analysis. Based on a \>2-fold increase in intensity, 8 spots showed \>2-fold upregulation in the gliotic as compared to normal retina, whilst 23 protein spots showed a \<0.5-fold decrease. In addition, all proteins observed differentially expressed were present in the Müller cell lysates ([Fig. 3](#fig3){ref-type="fig"}A and B). Proteins from 14 representative gel spots were extracted and digested prior to mass spectrometry to identify individual proteins. For each spot, the protein with the highest peptide count was considered the protein of interest. Proteins showing upregulation in the gliotic retina as compared to normal retina supported the current mass spectrometry observations that GFAP, vimentin and aminopeptidase are highly upregulated in during gliosis. Proteins identified to be downregulated in the gliotic retina as compared to normal retina by 2D-DIGE analysis included alpha enolase, N(G),N(G)-dimethyl arginine dimethylaminohydrolase-1, s-arrestin, GAPDH, and carbonic anhydrase 2 ([Table 3](#tbl3){ref-type="table"}).Fig. 3**2D-DIGE gel analysis of normal and gliotic human retina.** (A) Fluorescent gel image showing labelled proteins from a pool of 4 Müller glial cell preparations (Cy2 = green), 5 gliotic retinal specimens (Cy5 = Blue) and 4 normal retinae specimens (Cy3 = Red). (B) Representative 2D DIGE gel of a pool of 4 normal retina. Numbered protein spots are those shown to be differentially expressed between the gliotic and human retina by more than 2-fold. [Table 3](#tbl3){ref-type="table"} shows the protein identification of the numbered spots shown in this Figure. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 3Table 3**Differentially expressed proteins in the retina as identified by 2D DIGE.** Table shows the identification of protein spots highlighted in [Fig. 2](#fig2){ref-type="fig"} following mass spectral analysis. Fold differences in expression between normal retina (N), and gliotic retina (G) are shown.Table 3SpotUniprot IDAccessionPeptide countProtein nameFold differenceG/NSpot 788AMPL_HUMANP288385Cytosol aminopeptidase2.06Spot 1567GFAP_HUMANP1413638Glial fibrillary acidic protein2.05Spot 1568ENOA_HUMANP0673329Alpha-enolase0.45Spot 891ENOA_HUMANP0673325Alpha-enolase0.43Spot 1561DDAH1_HUMANO9476016N(G),N(G)-dimethylarginine dimethylaminohydrolase 10.45Spot 1603CAH2_HUMANP0091815Carbonic anhydrase 20.43Spot 820ARRS_HUMANP1052311S-arrestin0.27Spot 1553ARRS_HUMANP105233S-arrestin0.26Spot 1080DDAH1_HUMANO947604N(G),N(G)-dimethylarginine dimethylaminohydrolase 10.49Spot 831ARRS_HUMANP105233S-arrestin0.38Spot 1125G3P_HUMANP0440628GAPDH0.32Spot 1005VIME_HUMANP0867044Vimentin2.67Spot 759PDIA1_HUMANP0723717Protein disulphide-isomerase1.30Spot 943VIME_HUMANP0867066Vimentin2.13

3.4. Gene ontology and pathway classification and enrichment analysis of differentially expressed proteins in the retina {#sec3.4}
------------------------------------------------------------------------------------------------------------------------

Proteins upregulated in gliotic retina compared with normal retina were subject to gene ontology (GO) enrichment analysis to identify key areas of interest. Proteins grouped according to the GO term 'biological processes' revealed an over-representation associated with the intermediate filament cytoskeleton, astrocyte development, glial cell differentiation and negative regulation of neuron projection development ([Fig. 4](#fig4){ref-type="fig"}A) and included GFAP, vimentin and galectin 1. Similarly, enrichment analysis of upregulated proteins classified according to molecular function, showed structural constituents of the cytoskeleton significantly enriched in the gliotic retina ([Fig. 4](#fig4){ref-type="fig"}B) and included GFAP, vimentin, keratin and desmin. Other protein groups classified by molecular function found enriched, although not statistically significant, included iron-ion binding, NAD binding and actin binding proteins ([Fig. 4](#fig4){ref-type="fig"}B). Proteins upregulated in the gliotic retina as compared to normal retina were subject to IMPaLA pathway analysis. (The top 12 significantly over-represented pathways are shown in [Supplementary Table 3](#appsec1){ref-type="sec"}). The Liver Kinase B1- also known as Serine/Threonine Kinase 11 - STK11 (LKB1) signalling was the pathway most significantly represented within the group, and included the proteins HSP90aa1, ezrin, and 14.3.3δ. Other pathways highly represented included cellular responses to stress, regulation of serine/threonine-protein kinase 13 activity, also known as polo-like kinase 1 (PLK-1), G2/M transition and apoptosis ([Fig. 4](#fig4){ref-type="fig"}C).Fig. 4**Gene ontology and pathway analysis of proteins identified to be upregulated in the gliotic retina as compared to normal retina.** Figures have been simplified from WebGestalt GO, and IMPALA analysis results to show the classification and enrichment analysis of proteins found to be 2-fold upregulated in the gliotic retina as compared to normal retina. Gene ontology classifications highlighted in black represent statistically significant enriched gene ontology categories (P \< 0.05) (Benjamin and Hochberg false discovery rate correction), whereas those highlighted grey indicate those which are of the top 10 non-significantly enriched categories where P \> 0.05. Diagram shows GO categories and proteins assigned to those categories for (A) Biological processes (B) Molecular function. Similarly pathway analysis (C) shows the most significantly enriched signalling pathways of proteins 2-fold upregulated in the gliotic retina.Fig. 4

Of the proteins downregulated in the gliotic retina, classification according to biological processes revealed an over-representation of protein groups associated with bacterial signal recognition particle (SRP)-dependent co-translational protein targeting the membrane, mRNA catabolic processes, and translational termination ([Fig. 5](#fig5){ref-type="fig"}A). Enrichment analysis for downregulated proteins classified according to molecular function showed that GTPase activity, RNA binding, nucleotide binding, and structural constituents of the ribosome were also over-represented ([Fig. 5](#fig5){ref-type="fig"}B). Pathway analysis was also conducted for proteins shown to be downregulated in the gliotic retina as compared to normal retina. (The top 12 most significantly downregulated pathways are shown in [Supplementary Table 4](#appsec1){ref-type="sec"}). Eukaryotic translation elongation was most significantly represented within the group and included mainly ribosomal related proteins. Other pathways highly represented included eukaryotic translation termination, peptide chain elongation and nonsense mediated decay independent of the exon junction complex ([Fig. 5](#fig5){ref-type="fig"}C).Fig. 5**Gene ontology analysis of proteins identified to be downregulated in the gliotic retina as compared to normal retina**. Figures have been simplified from WebGestalt GO results to show the classification and enrichment analysis of proteins found to be \< 0.5-fold downregulated in the gliotic retina as compared to normal retina. Gene ontology classifications highlighted in black represent statistically significant enriched gene ontology categories (P \< 0.05) (Benjamin and Hochberg false discovery rate correction). Diagram shows GO categories and proteins assigned to those categories for (A) Biological processes (B) Molecular function. Similarly, pathway analysis (C) shows the most significantly enriched pathways of the proteins which were 2-fold downregulated in the gliotic retina.Fig. 5

3.5. Validation of retinal proteomic findings and localization of identified key proteins in Müller glia {#sec3.5}
--------------------------------------------------------------------------------------------------------

To validate our proteomics results we conducted western blot and immunofluorescence analyses. Using frozen sections of normal human retina (cadaveric) and gliotic specimens (PVR), we analysed the expression of the proteins GFAP, vimentin and galectin-1. Although the lamination of the gliotic retina examined was well preserved in the specimens examined, the overall morphological appearance is more irregular than that of the normal retina ([Fig. 6](#fig6){ref-type="fig"}A). Immunostaining of these specimens showed that Vimentin and GFAP was confined to the Müller glia end-feet region (nerve fibre layer; white arrows) in the normal retina. In comparison, Vimentin and GFAP immunostaining of PVR retina showed a widespread distribution of these proteins in Müller glia throughout the whole retinal section, this is one of the major characteristics of retinal gliosis ([Fig. 6](#fig6){ref-type="fig"}A). Immunostaining of normal retina for Galectin-1 was observed associated to Müller glia, more predominantly in the Müller end foot region, and spanning across all the layers of the retina. However, a more intense and widespread staining for this molecule was observed in Müller glia throughout the whole PVR retina ([Fig. 6](#fig6){ref-type="fig"}A). Similarly, western blot analysis of protein lysates from normal and gliotic retina showed an increased abundance of Vimentin, GFAP and Galectin-1 in the gliotic retina when compared with the normal retina ([Fig. 6](#fig6){ref-type="fig"}B).Fig. 6**Validation of proteomic profile (A)** Confocal images showing the expression of vimentin, GFAP and Galectin 1 by normal and gliotic human retina. As compared with normal retina, the gliotic retina showed a widespread and more intense staining for all three proteins, which was localized to Müller glia. White arrows show Müller end-feet; RGC = retinal ganglion cell layer; INL = inner nuclear layer; ONL = outer nuclear layer. Sections counterstained with DAPI to visualize retinal lamination. Scale bars: 20 μm **(B)** Western blot gels and corresponding histograms show an increase in vimentin, GFAP and Galectin-1 in the gliotic retinal specimens.Fig. 6

4. Discussion {#sec4}
=============

This study compared the protein expression profile of Müller glia with that of normal and gliotic PVR human retina and identified changes in cytoskeletal related proteins, extracellular matrix proteins and ribosomal proteins that occur during retinal gliosis. It would be important to analyse the proteome of Müller glia isolated from PVR gliotic retina with cells isolated from normal retina. However, in our laboratory, attempts to isolate Müller glia from PVR gliotic retina have been unsuccessful and we have been unable to obtain a stable culture of these cells despite many attempts (unpublished data). We hypothesise that this may be due to the gliotic nature of the tissue and the associated Müller glial changes that occur during gliosis ([@bib6]). For the current study, we therefore sought samples of PVR gliotic retina to compare these with normal retina and established human Müller glial cell lines isolated from normal retina. The results showed important variations in key proteins expressed in Müller glia and normal and gliotic retina that highlight a potential significance of these molecules during retina degeneration.

Many cytoskeletal proteins, including ezrin and desmin, which are highly expressed by established human Müller glial cell lines, although not classified in the top 30 proteins, were found \>2-fold upregulated in the gliotic retina. Upregulation of intermediate filament proteins, including GFAP and vimentin are generally accepted as indicators of retinal stress and Müller glial cell reactivity during retinal gliosis ([@bib17]; [@bib32]), and are further supported by observations in vimentin and GFAP deficient mice, in which decreased photoreceptor degeneration and attenuated glial reactions are observed ([@bib38]). Ezrin, a peripheral membrane protein which aids in the organisation of cell morphology ([@bib50]), has been found to be upregulated in a rabbit model of PVR ([@bib59]), suggesting that this protein may also be associated with human retinal gliosis. In zebrafish, Müller glia expression of GFAP is usually upregulated after retinal damage ([@bib46]), but upon regeneration GFAP expression is downregulated ([@bib47]). This suggests that GFAP may be more intricately regulated in Müller glia than first thought and that its expression may be potentially associated to the non-regenerative ability of these cells. These findings support previous observations of GFAP upregulation in the human gliotic retina, and highlight the importance of Müller cell structural changes in retinal remodelling during gliosis. These observations also indicate the importance to investigate the regulation of intermediate filament changes in human Müller glia that lead to these cells entering a gliotic state in favour of a progenitor-like state.

It is documented that extracellular matrix remodelling and gliosis occur in retinal diseases such as glaucoma ([@bib53]; [@bib57]), diabetic retinopathy ([@bib21]), PVR ([@bib28]) and AMD ([@bib39]). The findings that factors such as Tenascin C, PLOD2, CD166 and galectin1 are highly upregulated in gliotic retina, are therefore supported by these studies. Tenascin C is a glycoprotein involved in tissue remodelling and is known to support growth and differentiation. It is expressed in the ECM during development and injury ([@bib24]) and it is found upregulated during diabetic retinopathy ([@bib45]). It has been postulated that Tenascin contributes to mechanical stiffness of the retina ([@bib9]) and it is often co-expressed with matrix metalloproteinases (MMPs) ([@bib23]), suggesting its importance in the deposition of the extracellular matrix during reactive gliosis. Upregulation of Tenascin C has also been linked to growth factors and cytokines such as TGFβ1, interleukin 1 and TNFα ([@bib41]), which have been associated with retinal degenerative disorders ([@bib12]), suggesting that Tenascin C may contribute to gliosis. Galectin-1, a beta-galactoside-binding protein that plays an important role in cell adhesion and proliferation ([@bib8]), has been previously implicated in retinal disease. Neutralising galectin-1 activity in rat eyes is reported to increase susceptibility to retinal detachment due to weak RPE and neural retinal adhesion ([@bib49]). Although upregulation of this protein could promote neural retina-RPE integrity, it may also induce retinal traction that perpetuates retinal detachment in PVR. Since Müller glia was observed to highly express Galectin 1 within the retina ([Fig. 6](#fig6){ref-type="fig"}), it is possible that these cells are the main source of this protein in the retina and studies are needed to determine the role of this protein during gliosis. Although the cell adhesion molecule CD166 (also known as ALCAM) is expressed by retinal ganglion cell axons during retinal development ([@bib1]; [@bib10]), its role during retinal degeneration has yet to be explored and constitutes a valid target for future investigations.

The observations that retinal specific proteins such as rhodopsin, s-arrestin, recoverin, retinaldehyde binding protein, Thy1 and rod cGMP, were severely downregulated in the gliotic retina, may reflect the neural cell death observed during gliosis. The findings that retinoschisin, an extracellular protein that plays a crucial role in the cellular organisation of the retina, and glutamine synthetase, an enzyme that plays a key metabolic role within the retina, were also markedly decreased in the gliotic retina may indicate key metabolic changes occurring in Müller glia during gliosis ([@bib17]; [@bib31]; [@bib40]). Since downregulation of reticulon 4 (Neurite outgrowth inhibitor/Nogo) enhances neuronal cell growth and survival in the mouse retina ([@bib26]), the present findings that Nogo was downregulated in the gliotic retina may indicate the existence of endogenous mechanisms triggered during gliosis to protect neurons from further damage. Although the present study does not provide evidence for the cells involved in the downregulation of Nogo, or the mechanisms underlying its decreased expression in the gliotic retina, it justifies further studies into the mechanisms that regulate the expression of these factors in the developed retina.

Pathway analysis studies showed that LKB1 signalling was positively regulated in the gliotic retina as compared to normal retina. LKB1 signalling is involved in the control of cell growth and metabolism by phosphorylation of the AMPK metabolic sensor ([@bib34]), whilst HSP90AA1 bind and stabilise LKB1, possibly enhancing LKB1 signalling and cell growth inhibition ([@bib14]). Increased LKB1 signalling could lead to cell growth arrest and its upregulation during gliosis may reflect the damage observed. Several pathways involved in ribosomal processes were negatively regulated in the gliotic retina as compared to normal retina, suggesting that downregulation of the ribosomal subunits 40s and 60s may indicate a reduction in mRNA processing and protein translation during gliosis. In addition, loss of ribosome biogenesis is associated with ribosome stress, triggering activation of the p53 apoptotic pathway ([@bib55]), therefore the loss of ribosome function could be ascribed to cell death occurring during gliosis and investigations into the activation of these pathways in Müller glia may provide important information on how these cells are affected during gliosis.

Müller glia markers identified in Müller cell lysates included GFAP, vimentin, glutamine synthetase, CD44 antigen and retinaldehyde binding protein 1 (CRALBP). It is reported that retinal Müller glia lose these *in vivo* features and undergo senescence with passaging in culture ([@bib43]). Porcine Müller glia become fibroblastic after three days in culture and show upregulation of proteins associated with cytoskeleton, motility and proliferation, while downregulating those involved in transmitter recycling, glycolysis and detoxification ([@bib18]). In contrast, Müller glia that exhibit stem cell properties maintain their characteristic morphology ([@bib33]) and although they may undergo adaptation changes to culture environments, the present results showed that immortalized Müller cell lines express specific markers associated with Müller glia at high levels. This correlates with previous observations that Müller stem cells continue to express Müller glia markers after 100 passages ([@bib33]). We also identified proteins that have not previously reported to be expressed by Müller glia, including prelamin A/C, elongation factor 1, and serpin H1, for which it will be important to assess the functions of these factors during retinal gliosis. Additionally, markers highly expressed by Müller glia, including vimentin, GFAP, HSP90AA1 and poly-ubiquitin C, were also found \>2-fold upregulated in the gliotic retina. Ubiquitination is one of the most important post-translational modifications of proteins and is involved in various cellular activities, such as protein degradation, apoptosis, DNA transcription and repair, cell division, neural degeneration and stress responses amongst others ([@bib20]). It is possible that the main source of poly-ubiquitin C found in the gliotic retina is Müller glia, thus highlighting the contribution of these cells to the gliotic changes that occur in the retina after disease or injury. Controlling ubiquitination may therefore constitute an approach to control gliosis and merits further investigations.

The issue of missing data values in label free proteomics analysis via mass spectrometry is widely discussed in the literature and considered a major concern ([@bib30]). Analysis of our dataset was processed through Progenesis software, which has been reported to generate consistent accurate results and very few missing data values ([@bib51]). Although this software does not give a 'missing data rate' it does however produce some hits which are presented as having zero abundance which could be considered missing data and therefore these were excluded from our study.

In the present study it is possible that factors expressed by Müller glia may be under-represented in the retinal samples due to the presence of other retinal cell types. Nevertheless, variations in key proteins expressed in Müller glia and normal and gliotic retina highlight the importance of these molecules in retina degeneration. It also paves the way for further investigations into mechanisms that control the expression of gliosis associated proteins by Müller glia and their potential role in the prevention or promotion of endogenous regeneration of the adult mammalian retina.
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